Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Vaccinex, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 33 | 28 | −5 |
| Shares | 937.2K | 1.62M | +685.8K (+73.2%) |
| Value | $2.79M | $4.54M | +$1.75M (+62.7%) |
New holders (4)
Institutions that held Vaccinex, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 395,522 | $1.11M | 0.01% |
| State Street Corp | 67,200 | $188.0K | 0.00% |
| Simplex Trading, LLC | 2,325 | $6.00K | 0.00% |
| Cutler Group LP | 1,300 | $3.00K | 0.00% |
Sold out (9)
Institutions that held Vaccinex, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 53,780 | $161.0K |
| Marshall Wace, LLP | 43,215 | $129.0K |
| Bank of New York Mellon Corp | 17,954 | $54.0K |
| Natixis | 17,895 | $53.0K |
| Cetera Advisor Networks LLC | 10,500 | $31.0K |
| Clearstead Advisors, LLC | 300 | $1.00K |
| Bank of America Corp | 30 | $0 |
| Sowell Financial Services LLC | 100 | $0 |
| International Assets Investment Management, LLC | 100 | $0 |